Correlation Between ImmuPharma PLC and Calculus VCT
Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Calculus VCT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Calculus VCT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuPharma PLC and Calculus VCT plc, you can compare the effects of market volatilities on ImmuPharma PLC and Calculus VCT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Calculus VCT. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Calculus VCT.
Diversification Opportunities for ImmuPharma PLC and Calculus VCT
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between ImmuPharma and Calculus is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Calculus VCT plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calculus VCT plc and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Calculus VCT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calculus VCT plc has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Calculus VCT go up and down completely randomly.
Pair Corralation between ImmuPharma PLC and Calculus VCT
Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 15.16 times more return on investment than Calculus VCT. However, ImmuPharma PLC is 15.16 times more volatile than Calculus VCT plc. It trades about 0.08 of its potential returns per unit of risk. Calculus VCT plc is currently generating about -0.01 per unit of risk. If you would invest 138.00 in ImmuPharma PLC on November 3, 2024 and sell it today you would earn a total of 382.00 from holding ImmuPharma PLC or generate 276.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ImmuPharma PLC vs. Calculus VCT plc
Performance |
Timeline |
ImmuPharma PLC |
Calculus VCT plc |
ImmuPharma PLC and Calculus VCT Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ImmuPharma PLC and Calculus VCT
The main advantage of trading using opposite ImmuPharma PLC and Calculus VCT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Calculus VCT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calculus VCT will offset losses from the drop in Calculus VCT's long position.ImmuPharma PLC vs. Automatic Data Processing | ImmuPharma PLC vs. Alliance Data Systems | ImmuPharma PLC vs. Silver Bullet Data | ImmuPharma PLC vs. McEwen Mining |
Calculus VCT vs. Verizon Communications | Calculus VCT vs. Batm Advanced Communications | Calculus VCT vs. Qurate Retail Series | Calculus VCT vs. Seraphim Space Investment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |